McGillick Erin V, Te Pas Arjan B, van den Akker Thomas, Keus J M H, Thio Marta, Hooper Stuart B
The Ritchie Centre, Hudson Institute of Medical Research, Melbourne, VIC, Australia.
Department of Obstetrics and Gynaecology, Monash University, Melbourne, VIC, Australia.
Front Pediatr. 2022 Jun 23;10:878536. doi: 10.3389/fped.2022.878536. eCollection 2022.
Respiratory distress in the first few hours of life is a growing disease burden in otherwise healthy babies born at term (>37 weeks gestation). Babies born by cesarean section without labor (i.e., elective cesarean section) are at greater risk of developing respiratory distress due to elevated airway liquid volumes at birth. These babies are commonly diagnosed with transient tachypnea of the newborn (TTN) and historically treatments have mostly focused on enhancing airway liquid clearance pharmacologically or restricting fluid intake with limited success. Alternatively, a number of clinical studies have investigated the potential benefits of respiratory support in newborns with or at risk of TTN, but there is considerable heterogeneity in study designs and outcome measures. A literature search identified eight clinical studies investigating use of respiratory support on outcomes related to TTN in babies born at term. Study demographics including gestational age, mode of birth, antenatal corticosteroid exposure, TTN diagnosis, timing of intervention (prophylactic/interventional), respiratory support (type/interface/device/pressure), and study outcomes were compared. This narrative review provides an overview of factors within and between studies assessing respiratory support for preventing and/or treating TTN. In addition, we discuss the physiological understanding of how respiratory support aids lung function in newborns with elevated airway liquid volumes at birth. However, many questions remain regarding the timing of onset, pressure delivered, device/interface used and duration, and weaning of support. Future studies are required to address these gaps in knowledge to provide evidenced based recommendations for management of newborns with or at risk of TTN.
对于足月出生(妊娠>37周)的健康婴儿而言,出生后最初几个小时内的呼吸窘迫是一个日益加重的疾病负担。未经分娩通过剖宫产出生的婴儿(即择期剖宫产),由于出生时气道液体量增加,发生呼吸窘迫的风险更高。这些婴儿通常被诊断为新生儿暂时性呼吸急促(TTN),以往的治疗大多集中在通过药物增强气道液体清除或限制液体摄入,但成效有限。另外,一些临床研究调查了呼吸支持对患有或有TTN风险的新生儿的潜在益处,但研究设计和结局指标存在很大差异。一项文献检索确定了八项临床研究,这些研究调查了呼吸支持对足月出生婴儿与TTN相关结局的影响。比较了研究人口统计学特征,包括胎龄、出生方式、产前皮质类固醇暴露情况、TTN诊断、干预时机(预防性/干预性)、呼吸支持(类型/接口/设备/压力)以及研究结局。本叙述性综述概述了评估呼吸支持预防和/或治疗TTN的研究内部和之间的因素。此外,我们讨论了对呼吸支持如何帮助出生时气道液体量增加的新生儿肺功能的生理理解。然而,关于发病时间、输送压力、使用的设备/接口和持续时间以及支持的撤离,仍有许多问题。需要未来的研究来填补这些知识空白,为管理患有或有TTN风险的新生儿提供循证建议。